We compared the SLC12A5 protein levels in 49 paired tissues and confirmed that SLC12A5 protein levels were significantly enhanced in prostate cancer tissues compared with the matched adjacent normal tissues (P < 0.01) (Fig. 1C). This evidence concerns the gene SLC12A5 and prostate carcinoma.